Regis CEBE

Person

Saint-Louis, FR

People

Patents Grantslast 30 patents

Information Patent Grant
CD19 binding molecules and uses thereof
- Patent number 12,221,481
- Issue date Feb 11, 2025
- Novartis AG
- Brian Granda
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Methods of treating FGF21-associated disorders
- Patent number 11,802,152
- Issue date Oct 31, 2023
- Novartis AG
- Brian Boettcher
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
FGF21 mimetic antibodies and uses thereof
- Patent number 11,692,046
- Issue date Jul 4, 2023
- Novartis AG
- Regis Cebe
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Engineered heterodimeric proteins
- Patent number 11,685,776
- Issue date Jun 27, 2023
- Novartis AG
- Regis Cebe
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods of treating FGF21-associated disorders
- Patent number 11,236,159
- Issue date Feb 1, 2022
- Novartis AG
- Brian Boettcher
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
FGF21 mimetic antibodies and uses thereof
- Patent number 10,899,844
- Issue date Jan 26, 2021
- Novartis AG
- Regis Cebe
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
FGF21 MIMETIC ANTIBODIES AND USES THEREOF
- Publication number 20230416407
- Publication date Dec 28, 2023
- Novartis AG
- Regis CEBE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ENGINEERED HETERODIMERIC PROTEINS
- Publication number 20230295291
- Publication date Sep 21, 2023
- Novartis AG
- Regis CEBE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANGIOPOIETIN-LIKE 4 ANTIBODIES AND METHODS OF USE
- Publication number 20220213181
- Publication date Jul 7, 2022
- Novartis AG
- Regis CEBE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF TREATING FGF21-ASSOCIATED DISORDERS
- Publication number 20220162300
- Publication date May 26, 2022
- Novartis AG
- Brian BOETTCHER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FGF21 Mimetic Antibodies and Uses Thereof
- Publication number 20210171659
- Publication date Jun 10, 2021
- Novartis AG
- Regis CEBE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CD19 BINDING MOLECULES AND USES THEREOF
- Publication number 20210139585
- Publication date May 13, 2021
- Novartis AG
- Brian Granda
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF TREATING FGF21-ASSOCIATED DISORDERS
- Publication number 20200087392
- Publication date Mar 19, 2020
- Brian BOETTCHER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ENGINEERED HETERODIMERIC PROTEINS
- Publication number 20190382475
- Publication date Dec 19, 2019
- Novartis AG
- Regis CEBE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FGF21 MIMETIC ANTIBODIES AND USES THEREOF
- Publication number 20190040153
- Publication date Feb 7, 2019
- Novartis AG
- Regis CEBE
- C07 - ORGANIC CHEMISTRY

Person

Patents Grantslast 30 patents

CD19 binding molecules and uses thereof

Methods of treating FGF21-associated disorders

FGF21 mimetic antibodies and uses thereof

Engineered heterodimeric proteins

Methods of treating FGF21-associated disorders

FGF21 mimetic antibodies and uses thereof

Patents Applicationslast 30 patents

FGF21 MIMETIC ANTIBODIES AND USES THEREOF

ENGINEERED HETERODIMERIC PROTEINS

ANGIOPOIETIN-LIKE 4 ANTIBODIES AND METHODS OF USE

METHODS OF TREATING FGF21-ASSOCIATED DISORDERS

FGF21 Mimetic Antibodies and Uses Thereof

CD19 BINDING MOLECULES AND USES THEREOF

METHODS OF TREATING FGF21-ASSOCIATED DISORDERS

ENGINEERED HETERODIMERIC PROTEINS

FGF21 MIMETIC ANTIBODIES AND USES THEREOF